Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence-Reference-Cited by-同舟云学术

Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence

Published:2016-08-19 Issue:38 Volume:7 Page:62280-62291
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ueda Masami¹²,Iguchi Tomohiro¹,Masuda Takaaki¹,Nakahara Yujiro²,Hirata Hidenari¹,Uchi Ryutaro¹,Niida Atsushi³,Momose Kota²,Sakimura Shotaro¹,Chiba Kenichi³,Eguchi Hidetoshi¹,Ito Shuhei¹,Sugimachi Keishi¹⁴,Yamasaki Makoto²,Suzuki Yutaka⁵,Miyano Satoru³,Doki Yuichiro²,Mori Masaki²,Mimori Koshi¹

Affiliation:

1. Department of Surgery, Kyushu University Beppu Hospital, Beppu 874-0838, Japan

2. Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan

3. Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan

4. Department of Surgery, Fukuoka City Hospital, Fukuoka 812-0046, Japan

5. Laboratory of Functional Genomics, Department of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa 277-8562, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Tumor DNA Dynamics as Prognostic Markers in Locally Advanced and Metastatic Esophageal Squamous Cell Carcinoma;JAMA Surgery;2023-11-01

2. Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies;Onco;2023-07-15

3. Clinical predictors of early postoperative recurrence after radical esophagectomy for thoracic esophageal cancer;Esophagus;2023-05-24

4. cfSNV: a software tool for the sensitive detection of somatic mutations from cell-free DNA;Nature Protocols;2023-02-27

5. Tumor Burden Monitoring with Circulating Tumor DNA During Treatment in Patients with Esophageal Squamous Cell Carcinoma;Annals of Surgical Oncology;2023-02-14